SIGLA SCIENCES

Solutions for Market Access, Evidence, and Launch Excellence

Who We Are
What We Do
Case Studies
Get in Touch

We are life sciences leaders with deep industry expertise across Market Access, HEOR, Commercial Launch, and Digital Engagement. We deliver scalable, technology-powered solutions that help biopharma and health tech companies accelerate access, build evidence, and succeed in launch.

Our offering spans specialty disease areas with a particular focus on the strategies and tactics that deliver success in oncology, rare disease, and cell & gene therapies. We also know the diagnostics and devices spaces, and are pros at developing the alliances and partnerships that are critical to winning the market.

At Sigla Sciences, we accelerate market success through structured frameworks for access, contracting, partnerships, and engagement—built to scale across brands and launches.

 

We help leading biopharma and health tech companies succeed in a data-driven era of outcomes, access, and engagement by transforming evidence into compelling narratives and market impact. 

Mobirise

Oncology, Rare Disease, and CGT

We offer structured frameworks and playbooks designed for complex therapeutic areas. Our oncology, rare disease, and cell & gene therapy solutions integrate pricing models, access pathways, and evidence strategies—tested in the world’s most demanding markets.

Mobirise

Data & Digital

Our digital platforms combine analytics, AI, and engagement modules to turn raw data into actionable outcomes. These solutions plug directly into your launch and access strategy, delivering faster insights, stronger evidence, and measurable competitive advantage.

Mobirise

Platform + Expert Network Model

Our solution suite combines  digital platforms and tools with an expert-in-the-loop delivery model. Clients gain structured frameworks, tools, and data-driven modules, all backed by direct access to senior leaders and global specialists. This hybrid approach keeps overhead low, accelerates execution, and raises success rates compared to traditional agency models.

WANT TO HEAR FROM US?

Enter your email below to receive newsletters and updates. We email about once a month.

CONTACT US

Have a question or project in mind? Or, you can reach out and we'll talk about the current access, pricing, and policy landscape, an upcoming launch, or how AI and data can advance your objectives. Let's discuss!